SCHREIBER, R.; LEWIS, C.; CRANE, K. Patient Assessment of Foam Attributes from the Tazarotene Foam, 0.1%, Phase III Trials and Potential Impact on Patient Compliance. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S57, 2018. DOI: 10.25251/skin.2.supp.57. Disponível em: https://www.jofskin.org/index.php/skin/article/view/455. Acesso em: 5 jul. 2022.